Musculoskeletal ultrasound discriminating camptodactyly-arthropathy-coxa vara-pericarditis syndrome and juvenile idiopathic arthritis
By
Hatice Adigüzel Dundar
Faekah Gohar
Daniel Windschall
June 4, 2026
Clinical Scorecard: Differentiating Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome from Juvenile Idiopathic Arthritis Using Musculoskeletal Ultrasound
At a Glance
Category Detail
Condition
Key Mechanisms
Target Population Children with genetically confirmed CACP or active polyarticular JIA, emphasizing the need for genetic confirmation.
Care Setting
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
I n c l u d e s p e c i f i c p a r a m e t e r s f o r m o n i t o r i n g j o i n t e f f u s i o n s , s u c h a s s i z e a n d f r e q u e n c y o f e f f u s i o n s .
Risks
Patient & Prescribing Data
Elaborate on the consequences of using JIA treatments in CACP patients, highlighting potential harm.
Clinical Best Practices
Related Resources & Content